NOVT:NSD-Novanta Inc (USD)

COMMON STOCK | Scientific & Technical Instruments |

Last Closing

USD 168.83

Change

-2.20 (-1.29)%

Market Cap

USD 6.14B

Volume

0.19M

Analyst Target

USD 109.00
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Novanta Inc., together with its subsidiaries, provides precision medicine and manufacturing, medical solutions, and robotics and automation solutions in the United States and internationally. The company operates through three segments: Precision Medicine and Manufacturing, Medical Solutions, and Robotics and Automation. The Precision Medicine and Manufacturing segment offers photonics-based solutions, including laser scanning, beam delivery, CO2 laser, solid state laser, ultrafast laser, and optical light engine products serving photonics-based applications for industrial processing, metrology, medical and life science imaging, DNA sequencing, and medical laser procedures. The Medical Solutions segment provides a range of medical grade technologies, including medical insufflators, pumps, and related disposables; visualization solutions; wireless technologies, video recorders, and video integration technologies for operating room integrations; optical data collection and machine vision technologies; radio frequency identification technologies; thermal chart recorders; spectrometry technologies; and embedded touch screen solutions. The Robotics and Automation segment offers optical and inductive encoders, precision motors, servo drives and motion control solutions, integrated stepper motors, intelligent robotic end-of-arm technology solutions, air bearings, and air bearing spindles. The company sells its products through its direct sales force and distributors under the Cambridge Technology, Synrad, Laser Quantum, ARGES, WOM, NDS, Med X Change, Reach Technology, JADAK, ThingMagic, Photo Research, General Scanning, ATI Industrial Automation, Celera Motion, IMS, MicroE, Applimotion, Zettlex, Ingenia, and Westwind brands. The company was formerly known as GSI Group, Inc. and changed its name to Novanta Inc. in May 2016. Novanta Inc. was incorporated in 1968 and is headquartered in Bedford, Massachusetts.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-18 )

Largest Industry Peers for Scientific & Technical Instruments

Symbol Name Price(Change) Market Cap
TRMB Trimble Inc

-0.26 (-0.45%)

USD 13.80B
MKSI MKS Instruments Inc

-1.26 (-1.15%)

USD 7.53B
CGNX Cognex Corporation

-0.48 (-1.23%)

USD 6.63B
ITRI Itron Inc

-1.37 (-1.31%)

USD 4.61B
MLAB Mesa Laboratories Inc

+3.35 (+2.73%)

USD 0.68B
ITRN Ituran Location and Control Lt..

+0.05 (+0.18%)

USD 0.54B
FARO FARO Technologies Inc

+0.38 (+2.16%)

USD 0.34B
MVIS Microvision Inc

-0.02 (-1.74%)

USD 0.21B
LUNA Luna Innovations Incorporated

+0.04 (+1.86%)

USD 0.07B
SOTK Sono-Tek Corp

-0.10 (-2.47%)

USD 0.06B

ETFs Containing NOVT

LADR:XETRA L&G Optical Technology & .. 3.32 % 0.00 %

-0.09 (-0.28%)

N/A
ROBO:AU ETFS ROBO Global Robotics.. 2.05 % 0.00 %

+0.29 (+-0.28%)

USD 0.23B
IROB:XETRA L&G ROBO Global Robotics .. 2.05 % 0.00 %

-0.11 (-0.28%)

USD 0.91B
ROBO:SW L&G ROBO Global Robotics .. 2.05 % 0.00 %

-0.05 (-0.28%)

N/A
ROBE:LSE L&G ROBO Global Robotics .. 1.99 % 0.00 %

-0.10 (-0.28%)

USD 0.69B
ROBG:LSE L&G ROBO Global Robotics .. 1.99 % 0.00 %

-14.50 (-0.28%)

USD 0.69B
ROBO:LSE Legal & General UCITS ETF.. 1.99 % 0.00 %

-0.19 (-0.28%)

USD 0.69B
ROBO Robo Global® Robotics an.. 1.95 % 0.00 %

-0.17 (-0.28%)

USD 1.09B
ROBO Robo Global® Robotics an.. 1.95 % 0.95 %

-0.17 (-0.28%)

USD 1.09B
IROB:F Legal & General UCITS ETF.. 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Scientific & Technical Instruments) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 0.25% 59% D- 48% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 0.25% 59% D- 46% F
Trailing 12 Months  
Capital Gain 15.20% 82% B 65% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 15.20% 82% B 63% D
Trailing 5 Years  
Capital Gain 97.65% 100% F 84% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 97.65% 100% F 83% B
Average Annual (5 Year Horizon)  
Capital Gain 18.92% 91% A- 77% C+
Dividend Return 18.92% 91% A- 76% C+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 31.70% 86% B+ 59% D-
Risk Adjusted Return 59.68% 100% F 84% B
Market Capitalization 6.14B 84% B 90% A-

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.